Search

everythinglearnresearchcommunity

for

Search:↓

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

French maritime pine bark extract significantly increased hair density in menopausal women.

Certain variations of the HDAC9 gene can increase or decrease stroke risk in the Chinese population.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

A man developed a painful skin condition after multiple heart procedures involving radiation.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Early hair loss may be linked to metabolic syndrome.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Medications for PCOS don't seem to raise heart disease risk.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Melatonin improved mental health and metabolism in women with PCOS.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Facelifts can lead to high patient satisfaction and a quick recovery when done correctly.

COVID-19 can cause various skin issues, including rashes and lesions.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.